Federal Judge Blocks Planned Anthem-Cigna Deal -- Update
February 08 2017 - 8:11PM
Dow Jones News
By Brent Kendall and Anna Wilde Mathews
WASHINGTON -- A federal judge on Wednesday blocked health
insurer Anthem Inc. from acquiring rival Cigna Corp., the second
court ruling in recent weeks to deal a decisive rebuke to efforts
to reshape the industry through megamergers.
The decision, by U.S. District Judge Amy Berman Jackson, said
the proposed $48 billion deal violated federal antitrust law
because it would create an unacceptable reduction in the number of
companies that can serve large national employers that insure their
workers.
The ruling echoed a decision by a different judge last month who
blocked Aetna Inc.'s plans to take over Humana Inc. Though the two
proposed insurer combinations were different in many ways, the
message from the courts was similar: Judges found that merging top
industry rivals threatened higher prices and less service, with the
benefits of those deals failing to outweigh the potential
harms.
While Aetna is considering a possible appeal in its case,
Wednesday's ruling almost certainly kills the Anthem-Cigna
transaction, as discord between the companies has grown
considerably since they announced their deal in July 2015.
Neither company immediately responded to requests for
comment.
At the deal's inception, the insurers said their marriage would
create a diversified, innovative and more efficient health insurer.
But the two sides' relationship soured over time as they clashed
over leadership styles and visions for the future.
The companies squabbled during the Justice Department's review
of the transaction and eventually accused each other of violating
the merger agreement.
By the summer of 2016, merger integration planning between the
two companies had stopped, and during trial proceedings that began
in November, Anthem mounted a legal defense of the merger
singlehandedly. Cigna lawyers said very little during the
proceedings, and when they did so, it usually didn't help Anthem's
position.
Judge Jackson's ruling may open up a new chapter of hostilities,
especially because the merger agreement calls for Cigna to receive
a $1.85 billion breakup fee from Anthem if the deal dies.
Anthem has extended the deal's termination date to April 30, the
longest extension it can impose, but Cigna may push back against
efforts to keep it in the fold.
Obama administration antitrust enforcers at the Justice
Department filed simultaneous lawsuits last July to block the
Anthem and Aetna transactions. The court rulings blocking both
deals cement the Obama team's antitrust record of aggressive
enforcement that led to the demise of potentially market-changing
mergers in a host of industries.
A Justice Department spokesman didn't immediately respond to a
request for comment.
Health insurers found themselves swept up in the fever of the
recent merger boom. In 2015, the industry's major players engaged
in a deal dance that ended up with four of its biggest companies
paired off in ambitious bids to create a pair of behemoths with
more than $100 billion in annual revenue. Both proposed new
companies would still have been smaller than UnitedHealth Group
Inc., however.
The Justice Department had serious concerns about the rumored
insurance mergers before they were even officially announced. The
insurers were aware of these concerns but hoped they could overcome
them.
With Wednesday's ruling, it was clear the gamble didn't pay
off.
Now the insurers face a landscape transformed by the recent
Republican sweep into power. The Affordable Care Act could be
repealed and reshaped, while the Trump administration's antitrust
approach may prove different from that of Obama officials. Analysts
are already speculating that new managed-care deals may arise,
perhaps even involving new configurations among the four would-be
merger partners.
Anthem Chief Executive Joseph R. Swedish is likely to face
pressure from investors to quickly show how he will move forward
and generate growth. The final death of its Cigna deal would leave
the insurer lodged firmly behind UnitedHealth Group and still
lacking its own national platform for commercial insurance, the
type sold to employers and individuals.
In addition to a possible legal tussle with Cigna, Anthem faces
ongoing, high-stakes litigation with pharmacy-benefit manager
Express Scripts Holding Inc.
Anthem has struggled with its business on the ACA exchanges,
where there may be even more instability and uncertainty as
Republicans struggle to shape an alternative. Anthem has the
largest ACA business of any of its peers among the big publicly
traded insurers, and so far has retained it while others have
reduced their exposure amid losses. The company has said it would
consider pulling back next year if the marketplaces don't
improve.
Cigna, for its part, would remain the smallest of the major
publicly traded insurers, with revenue of $37.88 billion in 2015.
The deal would have brought it advantages of scale, including cost
savings and a likely greater ability to win favorable deals from
health-care providers.
Cigna Chief Executive David Cordani said at a recent investor
conference that if the Anthem deal didn't go through, Cigna could
have as much as $14 billion in cash and borrowings to deploy in
deal-making. He said the company's priorities include evaluating
"strategic M&A" and returning capital to shareholders. "We have
a strong track record of not letting capital lay idle," he
said.
Write to Brent Kendall at brent.kendall@wsj.com and Anna Wilde
Mathews at anna.mathews@wsj.com
(END) Dow Jones Newswires
February 08, 2017 19:56 ET (00:56 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cigna (NYSE:CI)
Historical Stock Chart
From Apr 2023 to Apr 2024